Literature DB >> 20643237

Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction.

Kohei Wakabayashi1, Manuel A Gonzalez, Cedric Delhaye, Itsik Ben-Dor, Gabriel Maluenda, Sara D Collins, Asmir I Syed, Michael A Gaglia, Rebecca Torguson, Zhenyi Xue, William O Suddath, Lowell F Satler, Kenneth M Kent, Joseph Lindsay, Augusto D Pichard, Ron Waksman.   

Abstract

Several reports have alluded to the adverse effect of chronic obstructive pulmonary disease (COPD) on long-term prognosis of patients with myocardial infarction (MI). Little information is available, however, regarding the effects of a decrease in cardiopulmonary reserve imposed by COPD on in-hospital outcome of acute MI. This study aimed to evaluate the impact of COPD on acute-phase outcome of patients with acute MI. From a cohort of 3,249 consecutive patients with ST-elevation MI who underwent primary or rescue percutaneous coronary intervention, 365 patients were identified as having coexistent COPD. Their clinical presentation and in-hospital outcome were compared to those of 2,884 patients without COPD. The primary end point was a composite of in-hospital death or cardiogenic shock on presentation. Patients with COPD were older (p <0.001), more often women (p <0.001), and smokers (p <0.001). They had higher prevalence of chronic renal insufficiency (p <0.001), systemic hypertension (p = 0.001), and diabetes mellitus (p = 0.01). Patients with COPD had higher rates of the composite end point of death or cardiogenic shock (p <0.0001). After multivariate analysis, COPD remained a strong independent predictor of the composite end point of death or cardiogenic shock (p = 0.008). In conclusion, COPD is a very strong predictor of hemodynamic compromise resulting in death or cardiogenic shock in patients presenting with ST-elevation MI. This observation suggests that hemodynamic and pulmonary consequences of COPD decrease the capacity of the circulatory system to adjust to the effects of acute MI. Recognition of the potential for combined therapy is vital. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20643237     DOI: 10.1016/j.amjcard.2010.03.026

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Detecting time-evolving phenotypic topics via tensor factorization on electronic health records: Cardiovascular disease case study.

Authors:  Juan Zhao; Yun Zhang; David J Schlueter; Patrick Wu; Vern Eric Kerchberger; S Trent Rosenbloom; Quinn S Wells; QiPing Feng; Joshua C Denny; Wei-Qi Wei
Journal:  J Biomed Inform       Date:  2019-08-22       Impact factor: 6.317

Review 2.  Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

Authors:  Vasiliki Petta; Fotis Perlikos; Stelios Loukides; Petros Bakakos; Athanasios Chalkias; Nicoletta Iacovidou; Theodoros Xanthos; Dorothea Tsekoura; Georgios Hillas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

3.  The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study.

Authors:  Mihaela S Stefan; Raveendhara R Bannuru; Darleen Lessard; Joel M Gore; Peter K Lindenauer; Robert J Goldberg
Journal:  Chest       Date:  2011-12-29       Impact factor: 9.410

4.  Effect of Chronic Obstructive Pulmonary Disease on In-Hospital Mortality and Clinical Outcomes After ST-Segment Elevation Myocardial Infarction.

Authors:  Manyoo Agarwal; Sahil Agrawal; Lohit Garg; Aakash Garg; Nirmanmoh Bhatia; Dipen Kadaria; Guy Reed
Journal:  Am J Cardiol       Date:  2017-03-01       Impact factor: 2.778

5.  Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction.

Authors:  Pontus Andell; Sasha Koul; Andreas Martinsson; Johan Sundström; Tomas Jernberg; J Gustav Smith; Stefan James; Bertil Lindahl; David Erlinge
Journal:  Open Heart       Date:  2014-02-03

6.  Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.

Authors:  Pere Almagro; Anna Lapuente; Julia Pareja; Sergi Yun; Maria Estela Garcia; Ferrán Padilla; Josep L I Heredia; Alex De la Sierra; Joan B Soriano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-16

7.  Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records.

Authors:  J K Quint; E Herrett; K Bhaskaran; A Timmis; H Hemingway; J A Wedzicha; L Smeeth
Journal:  BMJ       Date:  2013-11-22

8.  Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Koichi Nishimura; Takashi Nishimura; Katsuya Onishi; Toru Oga; Yoshinori Hasegawa; Paul W Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-02-05

9.  Ischemic ECG abnormalities are associated with an increased risk for death among subjects with COPD, also among those without known heart disease.

Authors:  Ulf Nilsson; Anders Blomberg; Bengt Johansson; Helena Backman; Berne Eriksson; Anne Lindberg
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-22

10.  Evaluation for airway obstruction in adult patients with stable ischemic heart disease.

Authors:  M Mahendra; Sunil Kumar S; Nagaraj Desai; Jayaraj Bs; Mahesh Pa
Journal:  Indian Heart J       Date:  2017-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.